519 related articles for article (PubMed ID: 33576380)
41. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
[TBL] [Abstract][Full Text] [Related]
42. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
[TBL] [Abstract][Full Text] [Related]
43. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
[TBL] [Abstract][Full Text] [Related]
44. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
45. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
46. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
[TBL] [Abstract][Full Text] [Related]
47. Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle.
Ramirez-Correa GA; Ma J; Slawson C; Zeidan Q; Lugo-Fagundo NS; Xu M; Shen X; Gao WD; Caceres V; Chakir K; DeVine L; Cole RN; Marchionni L; Paolocci N; Hart GW; Murphy AM
Diabetes; 2015 Oct; 64(10):3573-87. PubMed ID: 26109417
[TBL] [Abstract][Full Text] [Related]
48. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Collins HE; Chatham JC
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
[TBL] [Abstract][Full Text] [Related]
49. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
50. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
51. Nanomolar inhibition of human OGA by 2-acetamido-2-deoxy-d-glucono-1,5-lactone semicarbazone derivatives.
Kiss M; Szabó E; Bocska B; Sinh LT; Fernandes CP; Timári I; Hayes JM; Somsák L; Barna T
Eur J Med Chem; 2021 Nov; 223():113649. PubMed ID: 34186233
[TBL] [Abstract][Full Text] [Related]
52. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
[TBL] [Abstract][Full Text] [Related]
53. Fatty acid synthase inhibits the
Groves JA; Maduka AO; O'Meally RN; Cole RN; Zachara NE
J Biol Chem; 2017 Apr; 292(16):6493-6511. PubMed ID: 28232487
[TBL] [Abstract][Full Text] [Related]
54. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Kim G; Cao L; Reece EA; Zhao Z
Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244
[TBL] [Abstract][Full Text] [Related]
55. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
[TBL] [Abstract][Full Text] [Related]
56. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
57. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
58. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
Issad T; Al-Mukh H; Bouaboud A; Pagesy P
J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
[TBL] [Abstract][Full Text] [Related]
59. Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability.
Authier F; Ondruskova N; Ferenbach AT; McNeilly AD; van Aalten DMF
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38566589
[TBL] [Abstract][Full Text] [Related]
60. Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca
Ednie AR; Bennett ES
Basic Res Cardiol; 2020 Sep; 115(6):59. PubMed ID: 32910282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
